These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27615379)

  • 1. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis.
    Thonsri U; Seubwai W; Waraasawapati S; Sawanyawisuth K; Vaeteewoottacharn K; Boonmars T; Cha'on U
    Histol Histopathol; 2017 May; 32(5):503-510. PubMed ID: 27615379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
    Gu M
    Int J Clin Exp Pathol; 2015; 8(1):862-6. PubMed ID: 25755787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma.
    Sun Q; Zhao C; Xia L; He Z; Lu Z; Liu C; Jia M; Wang J; Niu J
    Int J Clin Exp Pathol; 2014; 7(9):6157-64. PubMed ID: 25337264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of neutrophil distribution in cholangiocarcinoma.
    Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L
    World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
    Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T
    World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
    Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.
    Cheng Q; Feng F; Zhu L; Zheng Y; Luo X; Liu C; Yi B; Jiang X
    Sci Rep; 2015 Nov; 5():16103. PubMed ID: 26534789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.
    Thuwajit P; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-In S
    J Gastroenterol Hepatol; 2008 May; 23(5):771-8. PubMed ID: 18410610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
    Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
    Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma.
    Rucksaken R; Charoensuk L; Pinlaor P; Pairojkul C; Khuntikeo N; Pinlaor S
    Cancer Biomark; 2017; 18(1):27-34. PubMed ID: 27814272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.
    Juntermanns B; Sydor S; Kaiser GM; Jaradat D; Mertens JC; Sotiropoulos GC; Swoboda S; Neuhaus JP; Meng W; Mathé Z; Baba HA; Canbay A; Paul A; Fingas CD
    Liver Int; 2015 Nov; 35(11):2448-57. PubMed ID: 25818805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
    Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.
    Chu X; Zhao P; Lv Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(1):328-36. PubMed ID: 25755719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas.
    Lee D; Do IG; Choi K; Sung CO; Jang KT; Choi D; Heo JS; Choi SH; Kim J; Park JY; Cha HJ; Joh JW; Choi KY; Kim DS
    Mod Pathol; 2012 Jan; 25(1):131-9. PubMed ID: 21874010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer.
    Komatsubara T; Oshiro H; Sakuma Y; Sata N; Niki T; Fukushima N
    Pathol Int; 2019 Feb; 69(2):86-93. PubMed ID: 30729623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX4 is associated with poor prognosis in cholangiocarcinoma.
    Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
    Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis.
    Zhou J; Shen W; He X; Qian J; Liu S; Yu G
    Int J Clin Exp Pathol; 2015; 8(9):9863-74. PubMed ID: 26617696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma.
    Huang YC; Chen M; Shyr YM; Su CH; Chen CK; Li AF; Ho DM; Chen YM
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1384-9. PubMed ID: 18624901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.